Author

Christian J. Bixby

Observed names: Bixby, Christian, Christian Bixby, Christian J. Bixby

Institution: Infinity (United States)

Observed institutions: Rutgers, The State University of New Jersey, National Institutes of Health, University of Pittsburgh, Frederick National Laboratory for Cancer Research, National Cancer Institute, Infinity (United States)

ORCID: 0000-0001-7831-5537

Observed ORCID: 0000-0001-7831-5537

OpenAlex ID: A5028615000

Multiple, Linked Human Immunodeficiency Virus Type 1 Drug Resistance Mutations in Treatment-Experienced Patients Are Missed by Standard Genotype Analysis

2005 · Sarah Palmer, Mary Kearney, et al. · Journal of Clinical Microbiology · 515

Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Is Comparable in Clinical Samples Preserved in Saline or Viral Transport Medium

2020 · Jared Radbel, Sugeet Jagpal, et al. · Journal of Molecular Diagnostics · 47

Identification of SARS-CoV-2 variants using viral sequencing for the Centers for Disease Control and Prevention genomic surveillance program

2022 · Chirayu Goswami, Michael Sheldon, et al. · BMC Infectious Diseases · 42

A Randomized Trial of Treatment Interruption before Optimized Antiretroviral Therapy for Persons with Drug‐Resistant HIV: 48‐Week Virologic Results of ACTG A5086

2006 · Constance A. Benson, Florin Vaida, et al. · The Journal of Infectious Diseases · 26

Clonal resistance analyses of HIV type-1 after failure of therapy with didanosine, lamivudine and tenofovir

2009 · Douglas Barnas, Dianna Koontz, et al. · Antiviral Therapy · 7

Additional file 1 of Identification of SARS-CoV-2 variants using viral sequencing for the Centers for Disease Control and Prevention genomic surveillance program

2022 · Goswami, Chirayu, Sheldon, Michael, et al. · Figshare

Works count: 8

Citation count: 637

H-index: 5

I10-index: 4